Q2055

curl https://api.healthcare.dev/v1/codes/hcpcs/Q2055 \
  -H "Authorization: Bearer $HDEV_API_KEY"

{
  "data": {
    "code": "Q2055",
    "parent": null,
    "status": "active",
    "system": "hcpcs",
    "display": "Idecabtagene vicleucel car",
    "billable": true,
    "attributes": {
      "betos": "O1D",
      "coverage": "C",
      "action_code": "N",
      "type_of_service": "1",
      "pricing_indicator": "51",
      "action_effective_date": "2024-04-04"
    },
    "description": "Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",
    "replaced_by": [],
    "effective_end": null,
    "effective_start": "2022-01-01",
    "care_categories": [
      "chemotherapy"
    ],
    "care_category_details": [
      {
        "slug": "chemotherapy",
        "name": "Chemotherapy and cancer medicines",
        "confidence": 0.95,
        "derivation": "source_stated",
        "evidence": [
          {
            "url": "https://www.cms.gov/medicare/coding-billing/healthcare-common-procedure-system/quarterly-update",
            "anchor": "HCPCS Level II range Q2041-Q2058"
          }
        ],
        "as_of": "2026-10-01T00:00:00.000Z"
      }
    ]
  },
  "meta": {
    "source": "cms-hcpcs",
    "data_version": "2026-10"
  }
}